Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document


Por: Bozkurt, B, Mullens, W, Leclercq, C, Russo, AM, Savarese, G, Böhm, M, Hill, L, Kinugawa, K, Sato, N, Abraham, WT, Bayes-Genis, A, Mebazaa, A, Rosano, GMC, Zieroth, S, Linde, C and Butler, J

Publicada: 1 jul 2025 Ahead of Print: 1 abr 2025
Resumen:
Guidelines for management of heart failure with reduced ejection fraction (HFrEF) emphasize personalized care, patient engagement, and shared decision-making. Medications and cardiac rhythm management (CRM) devices are recommended with a high level of evidence. However, there are significant disparities: patients who could benefit from devices are frequently referred too late or not at all. Misconceptions about device therapy and the notion that the needs of patients (especially the prevention of sudden cardiac death) can now be met by expanding drug therapies may play a role in these disparities. This state-of-the-art review is produced by members of the DIRECT HF initiative, a patient-centred, expert-led educational programme that aims to advance guideline-directed use of CRM devices in patients with HFrEF. This review discusses the latest evidence on the role of CRM devices in reducing HFrEF mortality and morbidity, and provides practical guidance on patient referral, device selection, implant timing and patient-centred follow-up.

Filiaciones:
Bozkurt, B:
 Baylor Coll Med, Houston, TX USA

Mullens, W:
 Ziekenhuis Oost Limburg, Genk, Belgium

 Hasselt Univ, Hasselt, Belgium

Leclercq, C:
 Univ Rennes, Rennes, France

Russo, AM:
 Rowan Univ, Cooper Med Sch, Camden, NJ USA

Savarese, G:
 Karolinska Inst, Stockholm, Sweden

Böhm, M:
 Saarland Univ, Homburg, Germany

Hill, L:
 Queens Univ Belfast, Belfast, North Ireland

Kinugawa, K:
 Univ Toyama, Toyama, Japan

Sato, N:
 Kawaguchi Cardiovasc & Resp Hosp, Saitama, Japan

Abraham, WT:
 Ohio State Univ, Sch Med, Columbus, OH USA

:
 Autonomous Univ Barcelona, CIBERCV, Barcelona, Spain

Mebazaa, A:
 Univ Paris Cite, MASCOT, APHP, Inserm Unit, Paris, France

Rosano, GMC:
 San Raffaele Open Univ Rome, Dept Human Sci & Promot Qual Life, Rome, Italy

 San Raffaele Cassino Hosp, Cardiol, Cassino, Italy

 IRCCS San Raffaele Roma, Rome, Italy

 City St Georges Univ London, Mol & Clin Sci Res Inst, Cardiol Clin Acad Grp, London, England

Zieroth, S:
 Univ Manitoba, Max Rady Coll Med, Winnipeg, MB, Canada

Linde, C:
 Karolinska Inst, Stockholm, Sweden

Butler, J:
 Baylor Scott & White Res Inst, Dallas, TX USA

 Univ Mississippi, Jackson, MS USA
ISSN: 13889842





European Journal of Heart Failure
Editorial
Wiley-Blackwell, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Estados Unidos America
Tipo de documento: Article
Volumen: 27 Número: 7
Páginas: 1242-1261
WOS Id: 001462248600001
ID de PubMed: 40204670
imagen Green Submitted

MÉTRICAS